Aryloxypropanolamine .beta. 3 adrenergic agonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 30, 1996
Grant Date -
N/A
app pub date -
Dec 2, 1994
filing date -
Dec 2, 1994
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein: R.sup.1 to R.sup.9 are as defined herein and m is the integer 0 or 1. These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity, gastrointestinal diseases and achalasia.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully